JP2004532209A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004532209A5 JP2004532209A5 JP2002576959A JP2002576959A JP2004532209A5 JP 2004532209 A5 JP2004532209 A5 JP 2004532209A5 JP 2002576959 A JP2002576959 A JP 2002576959A JP 2002576959 A JP2002576959 A JP 2002576959A JP 2004532209 A5 JP2004532209 A5 JP 2004532209A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- group
- compound
- fluoro
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 5
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 239000001257 hydrogen Substances 0.000 claims 3
- 229910052739 hydrogen Inorganic materials 0.000 claims 3
- 125000005842 heteroatoms Chemical group 0.000 claims 2
- 150000002431 hydrogen Chemical class 0.000 claims 2
- 125000001624 naphthyl group Chemical group 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 2
- 239000001301 oxygen Chemical group 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- MYMOFIZGZYHOMD-UHFFFAOYSA-N oxygen Chemical group O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 claims 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 2
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 239000011780 sodium chloride Substances 0.000 claims 2
- NINIDFKCEFEMDL-UHFFFAOYSA-N sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 2
- 239000011593 sulfur Chemical group 0.000 claims 2
- 229910052717 sulfur Inorganic materials 0.000 claims 2
- YBAWYTYNMZWMMJ-UHFFFAOYSA-N 2-(6-fluoro-1H-indol-3-yl)-N-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]ethanamine Chemical compound FC(F)C(F)(F)COC1=CC=CC(CNCCC=2C3=CC=C(F)C=C3NC=2)=C1 YBAWYTYNMZWMMJ-UHFFFAOYSA-N 0.000 claims 1
- KXOQNPANAFXKTN-UHFFFAOYSA-N 2-(6-fluoro-1H-indol-3-yl)-N-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]ethanamine;hydrochloride Chemical compound Cl.FC(F)C(F)(F)COC1=CC=CC(CNCCC=2C3=CC=C(F)C=C3NC=2)=C1 KXOQNPANAFXKTN-UHFFFAOYSA-N 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 125000001153 fluoro group Chemical group F* 0.000 claims 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Claims (4)
- 式
Xは、−O−、−NH−、−S−、−SO2−、−CH2−、−CH(F)−、−CH(OH)−、および−C(O)−からなる群から選択され;
R1は、場合により置換されたフェニル、場合により置換されたナフチル、イミダゾリル、および窒素、酸素、硫黄からなる群から選択される1個のヘテロ原子を有する、場合により置換された、5〜6員環の単環式芳香族複素環からなる群から選択され、該5〜6員環の単環式芳香族複素環は場合によりベンソ縮合しており;
R2は、水素およびC1−C3アルキルからなる群から選択され;
R3は、水素、フルオロ、およびメチルからなる群から選択され;
R4は、水素、アリル、C2−C4アルキル、フッ素化されたC2−C4アルキル、場合により置換されたフェニル、ナフチル、場合により置換されたフェニルスルホニル、場合により置換されたベンジル、および窒素、酸素、硫黄からなる群から選択される1または2個のヘテロ原子を有する、場合により置換された5〜6員環の単環式芳香族複素環からなる群から選択され、但し、Xが−SO2−、−CH2−、−CH(F)−、−CH(OH)−または−C(O)−であるとき、R4は場合により置換されたフェニルスルホニルでない]
で示される化合物またはその製薬的に許容し得る塩。 - 化合物が、N−(2−(6−フルオロ−1H−インドール−3−イル)エチル)−3−(2,2,3,3−テトラフルオロプロポキシ)ベンジルアミンまたはその製薬的に許容し得る塩である、請求項1に記載の化合物。
- 化合物が、N−(2−(6−フルオロ−1H−インドール−3−イル)エチル)−3−(2,2,3,3−テトラフルオロプロポキシ)ベンジルアミン塩酸塩である、請求項2記載の化合物。
- 請求項1記載の化合物および製薬的に許容し得る希釈剤を含有する医薬組成物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27992801P | 2001-03-29 | 2001-03-29 | |
US32944901P | 2001-10-15 | 2001-10-15 | |
PCT/US2002/005115 WO2002078693A2 (en) | 2001-03-29 | 2002-03-15 | N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2004532209A JP2004532209A (ja) | 2004-10-21 |
JP2004532209A5 true JP2004532209A5 (ja) | 2005-12-22 |
Family
ID=26959969
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2002576959A Pending JP2004532209A (ja) | 2001-03-29 | 2002-03-15 | 5−ht6受容体の拮抗薬としてのn−(2−アリールエチル)ベンジルアミン |
Country Status (29)
Country | Link |
---|---|
US (3) | US7157488B2 (ja) |
EP (1) | EP1379239B1 (ja) |
JP (1) | JP2004532209A (ja) |
KR (1) | KR100894189B1 (ja) |
CN (1) | CN1610547A (ja) |
AT (1) | ATE372768T1 (ja) |
AU (1) | AU2002303094B2 (ja) |
BR (1) | BR0208179A (ja) |
CA (1) | CA2442114C (ja) |
CY (1) | CY1110362T1 (ja) |
CZ (1) | CZ305838B6 (ja) |
DE (1) | DE60222396T2 (ja) |
DK (2) | DK1379239T3 (ja) |
DZ (1) | DZ3493A1 (ja) |
EA (1) | EA007493B1 (ja) |
ES (2) | ES2292758T3 (ja) |
HK (1) | HK1061649A1 (ja) |
HR (1) | HRP20030771B1 (ja) |
HU (1) | HU230322B1 (ja) |
IL (3) | IL157651A0 (ja) |
MX (1) | MXPA03008726A (ja) |
NO (1) | NO326160B1 (ja) |
NZ (1) | NZ527815A (ja) |
PL (1) | PL220721B1 (ja) |
PT (2) | PT1379239E (ja) |
SI (1) | SI1859798T1 (ja) |
SK (1) | SK287463B6 (ja) |
WO (1) | WO2002078693A2 (ja) |
ZA (1) | ZA200306795B (ja) |
Families Citing this family (82)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
AU2002303094B2 (en) * | 2001-03-29 | 2006-11-23 | Eli Lilly And Company | N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
EP1411925A1 (en) * | 2001-08-03 | 2004-04-28 | PHARMACIA & UPJOHN COMPANY | 5-arylsulfonyl indoles having 5-ht6 receptor affinity |
DK1523486T3 (da) | 2002-06-21 | 2008-03-03 | Suven Life Sciences Ltd | Tetracykliske arylsulfonylindoler med serotoninreceptor-affinitet |
NZ537635A (en) * | 2002-07-17 | 2006-11-30 | Lek Pharmaceuticals D | Novel derivatives of pyridylethanol (phenylethyl) amines as inhibitors of cholesterol biosynthesis, processes for their preparation, and pharmaceutical compositions containing them |
CA2499690C (en) | 2002-09-19 | 2011-05-24 | Eli Lilly And Company | Diaryl ethers as opioid receptor antagonist |
JP4897221B2 (ja) * | 2002-12-20 | 2012-03-14 | チバ ホールディング インコーポレーテッド | アミン類の合成及びその合成のための中間体 |
BRPI0407616A (pt) | 2003-03-07 | 2006-02-14 | Lilly Co Eli | composto, composição farmacêutica, método para bloquear uma combinação de receptor de mu, capa, delta (heterodìmero) deste em mamìferos, método para tratar ou prevenir obesidade e doenças relacionadas, uso de um composto, e método de suprimir o apetite em um paciente em necessidade deste" |
JP2006519855A (ja) | 2003-03-07 | 2006-08-31 | イーライ リリー アンド カンパニー | オピオイド受容体アンタゴニスト |
DE10320782A1 (de) * | 2003-05-09 | 2004-11-25 | Bayer Cropscience Ag | Substituierte Oxyarene |
DE602004000260T2 (de) | 2003-07-22 | 2006-08-24 | Arena Pharmaceuticals, Inc., San Diego | Diaryl- und arylheteroarylharnstoffderivate als modulatoren des 5-ht2a-serotoninrezeptors, die sich zur prophylaxe und behandlung von damit im zusammenhang stehenden erkrankungen eignen |
CN1894240A (zh) | 2003-12-22 | 2007-01-10 | 伊莱利利公司 | 阿片受体拮抗剂 |
US7381750B2 (en) | 2004-03-12 | 2008-06-03 | Eli Lilly And Company | Amino-phenoxymethyl-benzamide opioid receptor antagonists |
EP1735268B1 (en) | 2004-03-15 | 2012-02-15 | Eli Lilly And Company | Opioid receptor antagonists |
WO2005090303A1 (en) | 2004-03-15 | 2005-09-29 | Eli Lilly And Company | 4- (5- (aminomethyl) -indole-1-ylmethyl) -benzamide derivatives and related compounds as opioid receptor antagonists for the treatment of obesity |
US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
ME02970B (me) | 2004-06-24 | 2018-07-20 | Vertex Pharma | Modulatori atp-vezujućih kasetnih transportera |
EP1632491A1 (en) * | 2004-08-30 | 2006-03-08 | Laboratorios Del Dr. Esteve, S.A. | Substituted indole compounds and their use as 5-HT6 receptor modulators |
JP5156378B2 (ja) * | 2004-09-22 | 2013-03-06 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | MDM2とp53の間の相互作用の阻害剤 |
US7459469B2 (en) | 2004-11-10 | 2008-12-02 | Targacept, Inc. | Hydroxybenzoate salts of metanicotine compounds |
DE102004062542A1 (de) * | 2004-12-24 | 2006-07-06 | Bayer Cropscience Ag | Substituierte Oxyarene |
LT1993360T (lt) | 2005-12-28 | 2017-06-12 | Vertex Pharmaceuticals Incorporated | N-[2,4-bis(1,1-dimetiletil)-5-hidroksifenil]-1,4-dihidro-4-oksochinolin-3-karboksamido kieta forma |
JP5170742B2 (ja) * | 2005-12-28 | 2013-03-27 | 積水メディカル株式会社 | 凝集測定用試薬及び凝集測定方法 |
EP1973905A4 (en) * | 2006-01-06 | 2010-12-08 | Astrazeneca Ab | COMPOUNDS |
JP5162574B2 (ja) | 2006-03-22 | 2013-03-13 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Mdm2及びp53間の相互作用のインヒビターとしての環式アルキルアミン誘導体 |
JP5385125B2 (ja) * | 2006-03-22 | 2014-01-08 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | MDM2とp53の間の相互作用の阻害剤 |
TWI389889B (zh) | 2006-05-09 | 2013-03-21 | Targacept Inc | (2s)-(4e)-n-甲基-5-〔3-(5-異丙氧基吡啶)基〕-4-戊烯-2-胺之新穎多晶型 |
CN101528698A (zh) | 2006-05-09 | 2009-09-09 | 阿斯利康公司 | (2s)-(4e)-n-甲基-5-[3-(5-异丙氧基吡啶)基]-4-戊烯-2-胺的盐形式 |
EP1953153A1 (en) * | 2007-01-31 | 2008-08-06 | Laboratorios del Dr. Esteve S.A. | Heterocyclyl-substituted sulfonamides for the treatment of cognitive or food ingestion related disorders |
US8853406B2 (en) | 2007-08-06 | 2014-10-07 | Janssen Pharmaceutica Nv | Substituted phenylenediamines as inhibitors of the interaction between MDM2 and P53 |
JO2704B1 (en) * | 2007-09-21 | 2013-03-03 | جانسين فارماسوتيكا ان في | Interference inhibition factors between MD2 and B53 |
EP2209380A4 (en) * | 2007-10-09 | 2011-09-14 | Mark T Hamann | METHOD OF USE OF COMPOSITIONS WITH ANTIDEPRESSIVE EFFICACY, MOOD EFFICACY AND OTHER NEUROLOGICAL EFFECTIVENESS AND COMPOSITIONS THEREOF |
WO2009073118A1 (en) * | 2007-12-04 | 2009-06-11 | Merck & Co., Inc. | Tryptamine sulfonamides as 5-ht6 antagonists |
EP2508177A1 (en) | 2007-12-12 | 2012-10-10 | Glaxo Group Limited | Combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
US20090318527A1 (en) * | 2008-02-11 | 2009-12-24 | Howard Sard | Indole compounds and methods of use thereof |
US20110021538A1 (en) | 2008-04-02 | 2011-01-27 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
WO2010062321A1 (en) | 2008-10-28 | 2010-06-03 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2h-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea and crystalline forms related thereto |
US8541442B2 (en) | 2009-02-04 | 2013-09-24 | Janssen Pharmaceutica N.V. | Indole derivatives as anticancer agents |
EP2821400B1 (en) | 2009-03-20 | 2017-09-27 | Vertex Pharmaceuticals Incorporated | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
JP5083256B2 (ja) * | 2009-03-20 | 2012-11-28 | 株式会社デンソー | 半導体装置およびその製造方法 |
WO2011019738A1 (en) | 2009-08-10 | 2011-02-17 | Galenea Corporation | Compounds and methods of use thereof |
EP2311823A1 (en) | 2009-10-15 | 2011-04-20 | AC Immune S.A. | 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases |
TW201139370A (en) * | 2009-12-23 | 2011-11-16 | Lundbeck & Co As H | Processes for the manufacture of a pharmaceutically active agent |
FR2961097B1 (fr) * | 2010-06-09 | 2012-07-13 | Oreal | Procede cosmetique de traitement des odeurs corporelles humaines utilisant un compose 6-alkoxy tryptamine |
FR2961095B1 (fr) * | 2010-06-09 | 2012-06-15 | Oreal | Composition cosmetique et/ou dermatologique comprenant au moins un compose 6-alcoxy tryptamine |
US8293218B2 (en) * | 2010-07-29 | 2012-10-23 | Conopco, Inc. | Skin care compositions comprising substituted monoamines |
US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
WO2013130669A1 (en) | 2012-02-27 | 2013-09-06 | Vertex Pharmaceuticals Incorporated | Pharmaceutical composition and administration thereof |
UA112109C2 (uk) * | 2012-03-20 | 2016-07-25 | Адамед Сп. З О.О. | Сульфонамідні похідні бензиламіну для лікування захворювань центральної нервової системи (цнс) |
CN102746211B (zh) * | 2012-06-27 | 2015-05-27 | 上海泰坦化学有限公司 | 一种取代吲哚-3-甲醛类化合物的制备方法 |
JO3459B1 (ar) * | 2012-09-09 | 2020-07-05 | H Lundbeck As | تركيبات صيدلانية لعلاج مرض الزهايمر |
JP6440625B2 (ja) | 2012-11-14 | 2018-12-19 | ザ・ジョンズ・ホプキンス・ユニバーシティー | 精神分裂病を処置するための方法および組成物 |
US20160038484A1 (en) * | 2013-04-03 | 2016-02-11 | The University Of Utah Research Foundation | Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
CN104725249B (zh) * | 2013-12-20 | 2019-02-12 | 广东东阳光药业有限公司 | 苄胺类衍生物及其在药物上的应用 |
JO3639B1 (ar) * | 2014-07-04 | 2020-08-27 | H Lundbeck As | صورة متعددة الشكل جديدة لـ n-[2-(6-فلورو-1h-إندول-3-يل)إيثيل]-3-(2،2،3،3-تترا فلورو بروبوكسي)بنزيل أمين هيدروكلوريد |
AU2015330923B2 (en) | 2014-10-07 | 2020-03-12 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
ES2570452B1 (es) * | 2014-10-15 | 2017-04-19 | Fundación Para La Investigación Biomédida Del Hospital Universitario De La Princesa | Compuestos derivados de acrilato de 3-Alquilamino-1H-Indolilo y su uso en el tratamiento de enfermedades neurodegenerativas |
CN105175307A (zh) * | 2014-11-18 | 2015-12-23 | 苏州晶云药物科技有限公司 | Lu AE58054的盐酸盐晶型A及其制备方法和用途 |
CN104529865B (zh) * | 2014-12-12 | 2017-02-01 | 广东东阳光药业有限公司 | 苄胺类衍生物及其在药物上的应用 |
TW201630881A (zh) | 2014-12-12 | 2016-09-01 | H 朗德貝克公司 | 用於生產艾達魯吡啶之方法 |
JP2018516992A (ja) | 2015-06-12 | 2018-06-28 | アクソファント サイエンシーズ ゲーエムベーハーAxovant Sciences Gmbh | レム睡眠行動障害の予防および処置のために有用なジアリールおよびアリールヘテロアリール尿素誘導体 |
RU2018103338A (ru) | 2015-07-15 | 2019-08-15 | Аксовант Сайенсиз Гмбх | Производные диарил- и арилгетероарилмочевины для профилактики и лечения галлюцинаций, ассоциированных с нейродегенеративным заболеванием |
CN108271369A (zh) | 2015-10-23 | 2018-07-10 | 法尔玛赞公司 | 用于制备色胺及其衍生物的新工艺 |
JP2019513742A (ja) | 2016-04-08 | 2019-05-30 | ハー・ルンドベック・アクチエゼルスカベット | イミンの水素化によるイダロピルジンの製造方法 |
DK3448430T3 (da) * | 2016-04-26 | 2023-07-03 | H Lundbeck As | Anvendelse af en acetylcholinesterase-inhibitor og idalopirdin til reduktion af fald hos patienter med parkinsons sygdom |
US10864191B2 (en) | 2016-05-11 | 2020-12-15 | H. Lundbeck A/S | 5-HT6 receptor antagonists for use in the treatment of Alzheimer's disease with apathy as comorbidity |
WO2018013686A1 (en) * | 2016-07-12 | 2018-01-18 | Concert Pharmaceuticals, Inc. | Deuterated idalopirdine |
EP3333154A1 (en) | 2016-12-07 | 2018-06-13 | Sandoz Ag | Crystalline form of a selective 5-ht6 receptor antagonist |
CN106632303A (zh) * | 2017-01-09 | 2017-05-10 | 湖南华腾制药有限公司 | 一种6‑噻唑基吲哚衍生物的制备方法 |
US11339144B2 (en) | 2017-04-10 | 2022-05-24 | Navitor Pharmaceuticals, Inc. | Heteroaryl Rheb inhibitors and uses thereof |
BR112019001145A2 (pt) | 2017-05-24 | 2019-04-30 | H. Lundbeck A/S | combinação de um antagonista do receptor 5-ht6 e de um inibidor de acetilcolinesterase para uso no tratamento da doença de alzheimer em uma subpopulação de pacientes portadores de alelos de apoe4 |
CA3185336A1 (en) * | 2017-11-06 | 2019-05-09 | Acelot, Inc. | Small molecule drugs and related methods for treatment of diseases related to a.beta.42 oligomer formation |
US20220185815A1 (en) | 2019-03-06 | 2022-06-16 | Daiichi Sankyo Company, Limited | Pyrrolopyrazole derivative |
CN109942527A (zh) * | 2019-04-26 | 2019-06-28 | 新乡市润宇新材料科技有限公司 | 一种3-溴二苯并呋喃的合成方法 |
US20230219889A1 (en) | 2020-05-19 | 2023-07-13 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
KR20230061473A (ko) * | 2020-09-02 | 2023-05-08 | 인베릭 바이오사이언시스 캐나다 인크. | 니트로화된 실로시빈 유도체 및 5-ht2a 수용체를 조절하고 정신 장애를 치료하기 위한 이의 용도 |
CN117500788A (zh) * | 2021-03-02 | 2024-02-02 | 明德赛特制药公司 | 作为血清素能药物的用于治疗与之相关的疾病的吲哚衍生物 |
WO2022261240A2 (en) | 2021-06-08 | 2022-12-15 | ATAI Life Sciences AG | Dimethoxyphenylalkylamine activators of serotonin receptors |
CA3221823A1 (en) | 2021-06-09 | 2022-12-15 | Glenn Short | Novel prodrugs and conjugates of dimethyltryptamine |
WO2023044577A1 (en) * | 2021-09-24 | 2023-03-30 | Psygen Inc. | Recovery method for tryptamines |
WO2023129909A1 (en) | 2021-12-27 | 2023-07-06 | ATAI Life Sciences AG | Aminotetraline activators of serotonin receptors |
US20230357185A1 (en) | 2022-03-18 | 2023-11-09 | Enveric Biosciences Canada Inc. | C4-carboxylic acid-substituted tryptamine derivatives and methods of using |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3597149A (en) * | 1969-04-29 | 1971-08-03 | Showa Denko Kk | Inhibition of gas-fume fading of dyed cellulose acetate material |
FR2181559A1 (en) | 1972-04-28 | 1973-12-07 | Aec Chimie Organique Bio | N-Phenylalkyl-N-3-indolylalkyl-alkylamines - with sedative, neuroleptic, analgesic, hypotensive, antiserotonin, adrenolytic activity |
JPS5764632A (en) | 1980-10-09 | 1982-04-19 | Mitsui Toatsu Chem Inc | Novel 2-arylethyl ether derivative and thioether derivative, their production and insecticide and acaricide |
US5202336A (en) * | 1986-09-24 | 1993-04-13 | Bayer Aktiengesellschaft | Antiflammatory quinolin methoxy phenylsulphonamides |
DE3632329A1 (de) | 1986-09-24 | 1988-03-31 | Bayer Ag | Substituierte phenylsulfonamide |
SE9103745D0 (sv) | 1991-12-18 | 1991-12-18 | Wikstroem Haakan | Aryl-triflates and related compounds |
DE69411143T2 (de) | 1993-09-01 | 1998-10-22 | Allelix Biopharma | Tryptamin analoge mit 5-ht1d selektivität |
US5504101A (en) | 1994-05-06 | 1996-04-02 | Allelix Biopharmaceuticals, Inc. | 5-HT-1D receptor ligands |
DK1032559T3 (da) | 1997-09-29 | 2007-02-26 | Aventis Pharma Inc | Aminoalkylphenolderivater til behandling af depression og hukommelsessvigt |
GB9820113D0 (en) * | 1998-09-15 | 1998-11-11 | Merck Sharp & Dohme | Therapeutic agents |
WO2000034242A1 (en) * | 1998-12-11 | 2000-06-15 | Virginia Commonwealth University | Selective 5-ht6 receptor ligands |
BR9916905A (pt) * | 1999-01-13 | 2002-01-29 | Millennium Pharm Inc | Composto, composição farmacêutica, métodos para modular a atividade de um receptor de quimiocina, para prevenir infecção por hiv, tratar infecção por hiv, retardar o ìnicio de aids, ou tratar aids e para tratar uma doença inflamatória, e, combinação |
US6750348B1 (en) | 1999-03-24 | 2004-06-15 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds |
US6187895B1 (en) * | 1999-08-09 | 2001-02-13 | General Electric Company | Method for preparing polymers by solid state polymerization |
AU2002303094B2 (en) * | 2001-03-29 | 2006-11-23 | Eli Lilly And Company | N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor |
-
2002
- 2002-03-15 AU AU2002303094A patent/AU2002303094B2/en not_active Expired
- 2002-03-15 DK DK02731094T patent/DK1379239T3/da active
- 2002-03-15 CA CA2442114A patent/CA2442114C/en not_active Expired - Lifetime
- 2002-03-15 KR KR1020037012694A patent/KR100894189B1/ko active IP Right Grant
- 2002-03-15 JP JP2002576959A patent/JP2004532209A/ja active Pending
- 2002-03-15 CN CNA028105435A patent/CN1610547A/zh active Pending
- 2002-03-15 ES ES02731094T patent/ES2292758T3/es not_active Expired - Lifetime
- 2002-03-15 PT PT02731094T patent/PT1379239E/pt unknown
- 2002-03-15 IL IL15765102A patent/IL157651A0/xx unknown
- 2002-03-15 DE DE60222396T patent/DE60222396T2/de not_active Expired - Lifetime
- 2002-03-15 MX MXPA03008726A patent/MXPA03008726A/es active IP Right Grant
- 2002-03-15 NZ NZ527815A patent/NZ527815A/en not_active IP Right Cessation
- 2002-03-15 EA EA200301073A patent/EA007493B1/ru not_active IP Right Cessation
- 2002-03-15 AT AT02731094T patent/ATE372768T1/de active
- 2002-03-15 DK DK07015058.6T patent/DK1859798T3/en active
- 2002-03-15 US US10/472,741 patent/US7157488B2/en not_active Expired - Lifetime
- 2002-03-15 DZ DZ023493A patent/DZ3493A1/fr active
- 2002-03-15 SK SK1205-2003A patent/SK287463B6/sk unknown
- 2002-03-15 ES ES07015058.6T patent/ES2566056T3/es not_active Expired - Lifetime
- 2002-03-15 PT PT70150586T patent/PT1859798E/pt unknown
- 2002-03-15 HU HU0303651A patent/HU230322B1/hu unknown
- 2002-03-15 CZ CZ2003-2614A patent/CZ305838B6/cs not_active IP Right Cessation
- 2002-03-15 SI SI200231068A patent/SI1859798T1/sl unknown
- 2002-03-15 WO PCT/US2002/005115 patent/WO2002078693A2/en active IP Right Grant
- 2002-03-15 PL PL364458A patent/PL220721B1/pl unknown
- 2002-03-15 BR BR0208179-2A patent/BR0208179A/pt not_active Application Discontinuation
- 2002-03-15 EP EP02731094A patent/EP1379239B1/en not_active Expired - Lifetime
-
2003
- 2003-08-28 IL IL157651A patent/IL157651A/en active IP Right Grant
- 2003-08-29 ZA ZA2003/06795A patent/ZA200306795B/en unknown
- 2003-09-24 HR HR20030771A patent/HRP20030771B1/xx not_active IP Right Cessation
- 2003-09-25 NO NO20034289A patent/NO326160B1/no not_active IP Right Cessation
-
2004
- 2004-06-29 HK HK04104659A patent/HK1061649A1/xx not_active IP Right Cessation
-
2006
- 2006-12-11 US US11/608,922 patent/US20070099909A1/en not_active Abandoned
-
2007
- 2007-09-10 IL IL185871A patent/IL185871A0/en unknown
- 2007-11-27 CY CY20071101516T patent/CY1110362T1/el unknown
-
2009
- 2009-07-16 US US12/504,242 patent/US8044090B2/en not_active Expired - Fee Related
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2004532209A5 (ja) | ||
NO20014479L (no) | Fremgangsmåte ved behandling av spiseforstyrrelser | |
JP2003531118A5 (ja) | ||
JP2002543183A5 (ja) | ||
JP2002501049A5 (ja) | ||
JP2005053931A5 (ja) | ||
JP2007502806A5 (ja) | ||
CZ305838B6 (cs) | N-(2-arylethyl)benzylaminy jako antagonisté receptoru 5-HT6 | |
JP2005523922A5 (ja) | ||
JP2001526218A5 (ja) | ||
EE200300403A (et) | N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina | |
RU94036774A (ru) | Ингибирование пролиферации клеток гладкой мускулатуры и рестеноза | |
JP2004509857A5 (ja) | ||
DE60302157D1 (de) | Opioidrezeptorantagonisten | |
JP2007502817A5 (ja) | ||
JP2005511602A5 (ja) | ||
JP2005529164A5 (ja) | ||
JP2005507880A5 (ja) | ||
JP2004525184A5 (ja) | ||
JP2005510457A5 (ja) | ||
JP2004523545A5 (ja) | ||
JP2002514623A5 (ja) | ||
WO2000056315A8 (en) | Treatment of pain | |
DE60127535D1 (de) | Vorbeugende oder therapeutische mittel gegen gastrische oder ösophageale regurgitation | |
JP2005513103A5 (ja) |